Before semaglutide became a household name, liraglutide was the GLP-1 weight-loss drug. They come from the same company and the same class, but one is the daily workhorse that came first and the other is the once-weekly successor that largely replaced it. If you are weighing Saxenda against Wegovy, or Victoza against Ozempic, this is really a question of generations.
Liraglutide: The Original Daily GLP-1
Liraglutide was the breakthrough that proved GLP-1 drugs could drive meaningful weight loss. Sold as Victoza for type 2 diabetes and Saxenda for weight management, it is a daily injection — its shorter duration of action means it has to be taken every day. In its landmark SCALE weight-loss trial, liraglutide produced roughly 8% mean body-weight reduction, a result that was impressive at the time and opened the door for everything that followed.
Today liraglutide is the older option, and its patent has expired, which means generic versions have begun to appear — a genuine advantage on cost even as newer drugs outperform it on results.
Semaglutide: The Weekly Successor
Semaglutide is liraglutide’s more powerful descendant from the same maker. Sold as Ozempic and Wegovy, its key practical upgrade is dosing frequency: a longer half-life means a once-weekly injection instead of a daily one. It is also simply more effective — its STEP-1 obesity trial delivered about 15% mean weight loss, nearly double liraglutide’s SCALE result. For how semaglutide stacks up against the even newer dual agonist, see tirzepatide vs semaglutide, and for the two semaglutide brands, Ozempic vs Wegovy.
Liraglutide is the daily original; semaglutide is the once-weekly successor that roughly doubled the weight loss. Same class, same company, one generation apart.The generational gap in one line
Head to Head
When the two were compared directly in diabetes research, semaglutide came out ahead on both blood-sugar control and weight loss. That is not surprising — it was designed as the improved follow-up. The practical trade-offs come down to potency, convenience, and cost.
| Feature | Liraglutide | Semaglutide |
|---|---|---|
| Brands | Victoza, Saxenda | Ozempic, Wegovy |
| Dosing frequency | Daily injection | Once-weekly injection |
| Peak trial weight loss | ~8% (SCALE) | ~15% (STEP-1) |
| Generation | Older, first-wave | Newer successor |
| Generic availability | Yes (patent expired) | Limited / emerging |
| Cost | Often lower (generic) | Typically higher |
Which One — and Why
For most people whose priority is results and convenience, semaglutide is the stronger choice: roughly double the weight loss and one injection a week instead of seven. That is why it largely displaced liraglutide as the default. But liraglutide is not obsolete. Its daily dosing allows finer day-to-day control, some people tolerate it better, and — increasingly important — generic liraglutide can be significantly cheaper, which matters a great deal where semaglutide is unaffordable or unavailable. If cost or access is the deciding factor, the older drug still earns its place. Our Ozempic alternatives in Canada guide covers that angle, and the GLP-1 weight-loss drugs guide maps the full class.
Explore the full GLP-1 class, generics, and the research behind each compound in the TrueLabs library.
FAQ
Tap a question to reveal the answer.
What is the difference between semaglutide and liraglutide?
Both are GLP-1 receptor agonists from the same maker, but semaglutide is the newer, more potent, once-weekly successor to daily liraglutide. Semaglutide produces roughly double the weight loss and needs only one injection a week, while liraglutide is the older first-wave drug taken daily. Same class, one generation apart.
Is semaglutide better than liraglutide for weight loss?
On results, yes. Semaglutide delivered about 15% mean weight loss in STEP-1 versus roughly 8% for liraglutide in SCALE, and head-to-head diabetes research also favoured semaglutide. The main reasons to still choose liraglutide are cost, since generics exist, availability, or individual tolerance rather than effectiveness.
Is liraglutide daily or weekly?
Daily. Liraglutide has a shorter duration of action, so it is injected once a day. This is one of the biggest practical differences from semaglutide, which is injected just once a week thanks to its longer half-life. For many people the weekly schedule is a meaningful convenience advantage.
Is Saxenda the same as liraglutide?
Yes. Saxenda is the brand name for liraglutide approved for weight management, while Victoza is the same drug branded for type 2 diabetes. Like the Ozempic and Wegovy split for semaglutide, these are the same molecule under different names for different approved uses.
Is liraglutide cheaper than semaglutide?
Often, yes. Liraglutide’s patent has expired and generic versions have begun to appear, which can make it significantly cheaper than semaglutide. For people where semaglutide is unaffordable or unavailable, cheaper liraglutide can be a practical option despite its lower effectiveness.
Can you switch from liraglutide to semaglutide?
People do switch, typically for better results or the convenience of weekly dosing, but any switch between prescription medications should be managed by a clinician, who will handle the transition and dosing. It is a common path precisely because semaglutide is the stronger successor, but it is a medical decision.
Why did semaglutide replace liraglutide?
Because it was better on the two things that matter most to users: it produces greater weight loss and requires only weekly instead of daily injections. As the improved follow-up from the same company, semaglutide outperformed liraglutide in direct comparisons, so it naturally became the default where cost and access allow.
Related reading
- Tirzepatide vs semaglutide
- Ozempic vs Wegovy
- Ozempic alternatives in Canada
- GLP-1 weight-loss drugs guide
References
- Pi-Sunyer X, et al. Liraglutide for weight management, SCALE. New England Journal of Medicine, 2015.
- Wilding JPH, et al. Semaglutide in obesity, STEP-1. New England Journal of Medicine, 2021.
- SUSTAIN head-to-head data on semaglutide versus liraglutide in type 2 diabetes.
This article is informational and summarizes public information. It is not medical advice, a treatment protocol, or dosing guidance. Prescription medications should be used only under a licensed clinician, and any research compounds referenced are for laboratory use only. Always consult the current scientific literature and comply with local regulations.